Functional Roll for Non-alcoholic Fatty Liver Disease
NCT04520724 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2020-08-20
Summary
Background: Low physical activity and poor eating habits (incl. high fat and carbohydrates but low fiber intake) are the main reason of obesity epidemic in western societies. The most common clinical complication of this condition is non-alcoholic fatty liver disease (NAFLD), that can lead to liver cirrhosis and its complications. Recent studies show that gut dysbiosis may play a crucial role in the pathogenesis of NAFLD. On the other hand plant fiber shows beneficial properties in remodeling of the gut microbiome. Aim: The project aims to create low-calorie bars / snacks with an increased fiber content (12 g/bar), replacing the second breakfast and/or afternoon tea. The main scientific aim is to examine the influence of the extra supply of fiber on i. gut microbiota composition and metabolism and ii. liver function in patients with NAFLD. Methods: Randomized placebo-controlled double blind study. A group of patients diagnosed with NAFLD, divided into 2 groups: study (12% fiber bar) and placebo (maltodextrin bar). Two study phases: preliminary study (5 weeks, 20 patients) and main study (24 weeks, 120 patients). Both clinical and laboratory (stool and serum) aspects will be analyzed, incl. anthropometric measurements, nutrition tests (food frequency questionnaire), health-related quality of life, liver ultrasound and elastography, serum and stool biochemistry and microbiome analysis.
Conditions
- Non-Alcoholic Fatty Liver Disease
Interventions
- DIETARY_SUPPLEMENT
-
plant fiber
The patients with NAFLD (study and control group) will receive low-processed rolls with an 12 g plant fiber content twice daily, which would be a convenient for easy replenishment of the amount of vegetable fiber (act as prebiotic) in the diet. The intervention will be preceded by a 21 day wash-out period during which subjects will be asked to avoid foods containing large amount of fiber.
- DIETARY_SUPPLEMENT
-
maltodextrin bar
The patients with NAFLD (placebo group) will receive maltodextrin bars twice daily, which would be a convenient and easy-to-eat snack replacing the second breakfast and afternoon tea. The bars must be eaten with 180 ml of water or unsweetened liquid. The intervention will be preceded by a 21 day wash-out period during which subjects will be asked to avoid foods containing large amount of fiber.
Sponsors & Collaborators
-
Humboldt-Universität zu Berlin
collaborator OTHER -
Pomeranian Medical University Szczecin
lead OTHER
Principal Investigators
-
Ewa Stachowska, Professor · Department of Biochemistry and Human Nutrition
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-11-01
- Primary Completion
- 2019-09-01
- Completion
- 2019-11-01
Countries
- Poland
Study Locations
More Related Trials
-
Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)
NCT06127225 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment
NCT04308980 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot Study
NCT02457286 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of IDN-6556 in Subjects With NAFLD and Raised Transaminases
NCT02077374 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of High Protein Diet on Hepatic Steatosis in Patients With MAFLD
NCT06749704 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Manual Therapy in Metabolic Liver Disease
NCT06338618 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Nutritional Therapy With High Methionine Content in the Treatment of NAFLD
NCT04450875 ·Status: COMPLETED ·Phase: NA
-
Probiotics in the Treatment of NAFLD
NCT02764047 ·Status: UNKNOWN ·Phase: NA
-
Unravelling Mechanisms of Fructose vs Glucose Consumption in the Pathogenesis and Progression of NAFLD
NCT02075164 ·Status: UNKNOWN ·Phase: NA
-
Investigation of Synbiotic Treatment in NAFLD
NCT01680640 ·Status: COMPLETED ·Phase: NA
-
Metabolic Cofactor Supplementation in Obese Patients With Non-Alcoholic Fatty Liver Disease
NCT04330326 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Dihydromiricetin on MASLD
NCT05052515 ·Status: COMPLETED ·Phase: NA
-
Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD).
NCT05946330 ·Status: UNKNOWN ·Phase: NA
-
Development of a Novel Asian Mediterranean Diet and Its Acceptability in NAFLD
NCT06321211 ·Status: COMPLETED
-
Influence of Diabetic Control on the Degree of Liver Fibrosis Assessed by Non-invasive Scores in Patients Followed in Diabetology
NCT05605821 ·Status: NOT_YET_RECRUITING
-
Hepatic Mitochondrial Metabolism in Fatty Liver Disease in Humans
NCT06559878 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Fucoidan Improves the Metabolic Profiles of Patients With Non-alcoholic Fatty Liver Disease (NAFLD)
NCT02875392 ·Status: COMPLETED ·Phase: NA
-
Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment
NCT01002547 ·Status: COMPLETED ·Phase: PHASE4
-
Investigation on Safety and Efficacy of Soybean Fermented Extract (MBS217) in Treating Patients With NAFLD
NCT05686174 ·Status: UNKNOWN ·Phase: PHASE1
-
Different Doses of ZED1227 vs. Placebo in NAFLD
NCT05305599 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life in Non-alcoholic Fatty Liver Disease (QOLNAFLD)
NCT03613480 ·Status: UNKNOWN ·Phase: NA
-
Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis
NCT06308757 ·Status: RECRUITING ·Phase: NA
-
Assessment of Endothelial Function in Patients With Non Alcoholic Fatty Liver Disease and the Impact of Statin Treatment
NCT01987310 ·Status: WITHDRAWN ·Phase: NA
-
Digital Therapy for Fatty Liver Disease
NCT07007741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of Phlebotomy as a Treatment for Non-alcoholic Fatty Liver Disease
NCT00641524 ·Status: COMPLETED ·Phase: NA